ExeVir's XVR011, a best in class nanobody-based biology that broadly neutralizes SARS-COV-1 and SARS-COV-2
De performantie van speekselstalen voor de moleculaire detectie van SARS-CoV-2 en een speeksel pooling strategie als diagnostische tool voor epidemiologische studies in de huidige SARS-CoV-2 pandemie.
Opvolging van SARS-CoV-2 specifieke immuniteit na COVID-19 vaccinatie in bewoners en medewerkers van woonzorgcentra
SARS-CoV-2 seroprevalence among nursing home residents in March 2022 : brief communication on results of the scope-2 study (SARS-COV-2 seroprevalence)
Man-specific lectins from plants, fungi, algae and cyanobacteria, as potential blockers for SARS-CoV, MERS-CoV and SARS-CoV-2 (COVID-19) coronaviruses : biomedical perspectives
Diagnostic performance of the SARS-CoV-2 S1RBD IgG ELISA (immunodiagnostics) for the quantitative detection of SARS-CoV-2 antibodies on dried blood spots
A dual-antigen self-amplifying RNA SARS-CoV-2 vaccine induces potent humoral and cellular immune responses and protects against SARS-CoV-2 variants through T cell-mediated immunity
Serological response in health care workers after a single dose of SARS-CoV-2 vaccine using six automated SARS-CoV-2 antibody assays
Coordinates of docked compounds from manuscript "Azapeptide activity-based probes for the SARS-CoV-2 main protease enable visualization of inhibition in infected cells"
Seroprevalence of IgG antibodies against SARS coronavirus 2 in Belgium – a serial prospective cross-sectional nationwide study of residual samples